Accès gratuit
Med Sci (Paris)
Volume 18, Numéro 4, Avril 2002
Page(s) 395 - 397
Section Le Magazine : Nouvelles
Publié en ligne 15 avril 2002
  1. MacLean M, Herve P, Eddahibi S, Adnot S. 5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary hypertension. Br J Pharmacol 2000; 131 : 161–8.
  2. Eddahibi S, Raffestin B, Pham I, et al. Treatment with 5-hydroxytryptamine potentiates development of pulmonary hypertension in chronically hypoxic rats. Am J Physiol 1997; 272 : H1173–81.
  3. Eddahibi S, Raffestin B, Launay JM, Sitbon M, Adnot S. Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia. Am J Respir Crit Care Med 1998; 157 : 1111–9.
  4. Eddahibi S, Fabre V, Boni C, et al. Induction of serotonin-transporter by hypoxia in pulmonary vascular smooth muscle cells: relationship with the mitogenic action of serotonin. Circ Res 1999; 84 : 329–36.
  5. Eddahibi S, Hanoun N, Frisdal E, et al. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 2000; 105 : 1555–62.
  6. Eddahibi S, Humbert M, Fadel E, et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001; 108 : 1141–50.
  7. Lesch K P, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274 : 1527–31.